The US FDA has approved Bristol Myers Squibb’s oral medicine, Cobenfy, for treating schizophrenia in adults. This is the first new type of medication in decades that alleviates symptoms without common side effects. Available by late October, the drug will cost $1,850 monthly before insurance and rebates.
Related Posts
Vande Metro launch date, schedule: PM Modi to flag off Bhuj-Ahmedabad Vande Metro train; check timings, stoppages of new Indian Railways train
Vande Metro timings: Prime Minister Narendra Modi will flag off the first Vande Metro train on September 16, 2024. Operating between Bhuj and Ahmedabad, this […]
Stock markets brace for RBI’s monetary policy decisions after GDP growth slowdown
Domestic stock indices in India are preparing for RBI’s monetary policy decisions after Q2 FY25 GDP growth slowed to 5.4%, the lowest in two years. […]
From December 28, higher compensation for international flyers for death, delay
ICAO has increased compensation limits for international flight issues under the Montreal Convention, effective Dec 28. The new upper limit for death compensation rises from […]